Nrf2/Keap 1 complex disrupting agents (UCB Pharma/Evotec)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNrf2/Keap 1 complex disrupting agents (UCB Pharma/Evotec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 inhibitors
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsInflammationImmune System DiseasesNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUcb Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvotec (UK) LtdUcb Pharma Ltd
Active IndicationsN/A
Inactive IndicationsInflammationImmune System DiseasesNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A